← FDA Drug Approvals (Drugs@FDA)

LUMENHANCE

NDA · New Drug Application · Sponsor: BRACCO · Approved 1997-12-19

Drug application

FDA Application #

NDA020686

Application type

New Drug Application

Brand name

LUMENHANCE

Generic name

Manganese Chloride Tetrahydrate

Active ingredients

MANGANESE CHLORIDE TETRAHYDRATE

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

BRACCO

First approval

1997-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown